Aviir, Inc. Completes $30 Million Series B Preferred Stock Financing

Represented Aviir, Inc. in connection with its $30 million Series B financing.

Founded in 2005 by a group of cardiologists and researchers from the Stanford University School of Medicine, Aviir dedicates its efforts to the prevention and control of cardiovascular disease and metabolic syndromes.